Advertisement

Topics

ReproCELL, Inc. Company Profile

20:42 EST 11th December 2018 | BioPortfolio

“ReproHP Medium,” a highly functional culture fluid for human primary liver cells developed in conjunction with the National Cancer Center, is set to go on sale in December this year. Read on for details.


News Articles [6 Associated News Articles listed on BioPortfolio]

Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow

New headquarters strengthen drug discovery services and translational research, and generate new employment opportunities in Scotland.Glasgow, UK. 10th August 2017: REPROCELL Europe Ltd (REPROCELL), a...

ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

Funding will be used to improve efficiency of induced pluripotent stem cell production Edinburgh, UK and Glasgow, UK: ROSLINCT, a leading cell and gene therapy contract manufacturing organisat...

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation mater...

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation mater...

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell technologies. The company offers products through its divisions such as research reagents, cultivat...

Global Scaffoldfree Cell Culture Product Market Status and Outlook 20182025 [Report Updated: 12082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ReproCELL Inc.

ReproCELL, Inc.

“ReproHP Medium,” a highly functional culture fluid for human primary liver cells developed in conjunction with the National Cancer Center, is set to go on sale in Decem...

More Information about "ReproCELL, Inc." on BioPortfolio

We have published hundreds of ReproCELL, Inc. news stories on BioPortfolio along with dozens of ReproCELL, Inc. Clinical Trials and PubMed Articles about ReproCELL, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReproCELL, Inc. Companies in our database. You can also find out about relevant ReproCELL, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record